IL2, interleukin 2, 3558

N. diseases: 950; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.330 Biomarker phenotype BEFREE We therefore evaluated the safety, tolerability, and antitumor activity of hu14.18-IL2 given with GM-CSF and isotretinoin in a schedule similar to standard MRD therapy. 31358541 2019
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.330 Biomarker phenotype BEFREE New approaches to treating neuroblastoma MRD that are in early clinical trials include the cytotoxic retinoid fenretinide and the hu14.18-IL2 immunocytokine. 15125707 2004
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.330 Therapeutic phenotype CTD_human Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF. 14654953 2004
CUI: C0242596
Disease: Neoplasm, Residual
Neoplasm, Residual
0.330 Biomarker phenotype BEFREE Has IL2 a role in the management of minimal residual disease for acute leukemia? 1434844 1992